InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Peterson Kristine, 董事. Officer active across 2 companies, notably Paratek Pharmaceuticals, Inc.. Cumulatively, 5 reports have been recorded. History available since 16 February 2022. The latest transaction was disclosed on 30 November 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Peterson Kristine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
10,000 股@ US$10.1040.2% 占其流量Common StockSEC:0001415889-23-015908:0
59,000 股Common StockSEC:0000899243-23-019363:0
10,000 股@ US$14.7059.8% 占其流量Common StockSEC:0001415889-23-013292:0
20,000 股0Common StockSEC:0000904454-23-000107:0
20,000 股0Common StockSEC:0000904454-22-000169:0
5 条申报中的 5 条
About Peterson Kristine
Peterson Kristine is Administrateur at Paratek Pharmaceuticals, Inc. and ImmunoGen, Inc. She has 5 filings in total, and within the sampled recent filings the period runs from 2022-02-18 to 2023-12-05, with transactions dominated by option exercise.
